BIO-key International (NASDAQ:BKYI) Upgraded at ValuEngine

ValuEngine upgraded shares of BIO-key International (NASDAQ:BKYI) from a hold rating to a buy rating in a research report report published on Thursday morning, ValuEngine reports.

Separately, Maxim Group reaffirmed a buy rating and set a $2.25 price objective on shares of BIO-key International in a research report on Monday, July 29th.

Shares of NASDAQ BKYI traded down $0.06 during trading hours on Thursday, reaching $1.22. The stock had a trading volume of 526 shares, compared to its average volume of 5,429. The company has a quick ratio of 1.56, a current ratio of 2.15 and a debt-to-equity ratio of 0.05. BIO-key International has a fifty-two week low of $0.75 and a fifty-two week high of $2.13. The business’s 50-day simple moving average is $1.24.

BIO-key International (NASDAQ:BKYI) last announced its earnings results on Wednesday, May 15th. The technology company reported ($0.13) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.04) by ($0.09). The firm had revenue of $0.55 million during the quarter. BIO-key International had a negative net margin of 172.60% and a negative return on equity of 60.41%.

About BIO-key International

BIO-key International, Inc develops and markets fingerprint biometric identification and identity verification technologies, authentication-transaction security technologies, and related identity management and credentialing biometric hardware and software solutions. Its solutions enable application developers, value added resellers, and channel partners to integrate fingerprint biometrics into their applications.

Recommended Story: Leveraged Buyout (LBO)

To view ValuEngine’s full report, visit ValuEngine’s official website.

Receive News & Ratings for BIO-key International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BIO-key International and related companies with MarketBeat.com's FREE daily email newsletter.